发明名称 |
1,3,5-TRIAZINE-2,4,6-TRIAMINE COMPOUND OR PHARMACEUTICAL ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |
摘要 |
Disclosed herein are a 1,3,5-triazine-2,4,6-triamine compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a composition for preventing or treating metabolic syndromes, diabetes, or cancers with deletion of P53 gene, which comprises the same. |
申请公布号 |
WO2009028891(A3) |
申请公布日期 |
2009.04.30 |
申请号 |
WO2008KR05062 |
申请日期 |
2008.08.28 |
申请人 |
HANALL PHARMACEUTICAL COMPANY. LTD;KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY;CHEON, HYAE GYEONG;KIM, KWANG-ROK;RHEE, SANG DAL;JUNG, WON HOON;LEE, JONG-CHEOL;KIM, SUNG WUK;JUN, SUNG SOO |
发明人 |
CHEON, HYAE GYEONG;KIM, KWANG-ROK;RHEE, SANG DAL;JUNG, WON HOON;LEE, JONG-CHEOL;KIM, SUNG WUK;JUN, SUNG SOO |
分类号 |
C07D251/54 |
主分类号 |
C07D251/54 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|